A new essential downstream component of the wingless signalling pathway
CA 2441706 A1 · Owner: The Genetics Company · Inventors: Kramps, Thomas; Basler, Konrad
Overview
Its claims, description and drawings are in the Canadian Patents Database.
Open the CIPO recordAbstract From the Canadian patent
The present invention relates to a new essential downstream component of the wingless signaling pathway. In particular the invention relates to nucleotide , sequences of the Drosophila melanogaster daughter of legless (doll) gene of , its encoded proteins, as well as derivatives fragments and analogues thereof. , The invention includes vertebrate and invertebrate homologues of the Doll protein, comprising proteins that contain a stretch of amino acids with similarity to the Drosophila Doll gene. Methods for producing the Doll protein, derivatives and analogs, e.g. by recombinant means and antibodies to , Doll are provided by the present invention as well. The invention also relates to …
Read the whole patent
Listed from its CIPO record in Patent Yard's archive of Canadian patents past their term. Its claims, description and drawings are in the CIPO record and on Google Patents, and the Claude kit works from them.
Why it's free to use
- Filed February 1, 2002. No grant is recorded for it in Canada; had it been granted, its 20-year term would have ended February 1, 2022.
- A certificate of supplementary protection adds at most two years for a drug, so even that would have ended by February 1, 2024.
- We check Canadian rights only. A patent in its family in another country could still be in force: check its family on Google Patents.
Timeline
Timeline From CIPO dates
Sources & verification
Official CIPO records
Everything on this page comes from the CIPO record linked above. Contains information licensed under the Open Government Licence – Canada.